← Study Library
Animal · 2024
Preclinicalcounts toward this tierUpregulated Tβ4 expression in inflammatory bowel disease impairs the intestinal mucus barrier by inhibiting autophagy in mice
Hao M, Zhong K, Bai X, Wu S, Li L, He Y, Wang Z, Sun X, Wang Q, Guo Y, Sun Y, Wu L · Experimental Cell Research
Preclinicalcounts toward this tier
Injected Tβ4 damaged the colonic mucus barrier, suppressed mucin-2, disrupted tight junctions and downregulated autophagy — an administered-peptide harm signal in a tissue nobody was targeting.
- Population
- Mice with DSS-induced colitis; Caco-2 cells and normal human colon tissue
- Intervention
- Intraperitoneal thymosin β4
- Comparator
- Untreated mice
- Limitations
- One mouse colitis model; the doses and route are not those used in human trials, and no human gastrointestinal signal has been reported.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental